Steward Partners Investment Advisory’s ADMA Biologics ADMA Stock Holding History

Steward Partners Investment Advisory’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62.8K	Buy	7,500 +1,438	+24%	+$13.1K	﹤0.01%	2818
2026 Q1	$54.6K	Buy	6,062 +4,500	+288%	+$71K	﹤0.01%	2734
2025 Q4	$28.5K	Buy	1,562 +500	+47%	+$8.43K	﹤0.01%	2976
2025 Q3	$15.6K	Sell	1,062 -750	-41%	-$12.9K	﹤0.01%	3195
2025 Q2	$33K	Sell	1,812 -938	-34%	-$19.1K	﹤0.01%	2678
2025 Q1	$54.6K	Buy	2,750 +488	+22%	+$8.44K	﹤0.01%	2340
2024 Q4	$38.8K	Sell	2,262 -9,166	-80%	-$172K	﹤0.01%	2468
2024 Q3	$228K	Buy	11,428 +10,428	+1,043%	+$162K	﹤0.01%	1465
2024 Q2	$11.2K	Hold	1,000	–	–	﹤0.01%	2770
2024 Q1	$6.6K	Hold	1,000	–	–	﹤0.01%	2959
2023 Q4	$4.52K	Hold	1,000	–	–	﹤0.01%	2999
2023 Q3	$3.58K	Hold	1,000	–	–	﹤0.01%	2930
2023 Q2	$3.69K	Hold	1,000	–	–	﹤0.01%	2888
2023 Q1	$3.31K	Hold	1,000	–	–	﹤0.01%	2912
2022 Q4	$3.88K	Hold	1,000	–	–	﹤0.01%	2857
2022 Q3	$2K	Hold	1,000	–	–	﹤0.01%	2995
2022 Q2	$2K	Hold	1,000	–	–	﹤0.01%	2972
2022 Q1	$2K	Hold	1,000	–	–	﹤0.01%	3064
2021 Q4	$1K	Sell	1,000 -3,000	-75%	-$3.94K	﹤0.01%	3066
2021 Q3	$5K	Hold	4,000	–	–	﹤0.01%	2789
2021 Q2	$6K	Hold	4,000	–	–	﹤0.01%	6423
2021 Q1	$7.04K	Hold	4,000	–	–	﹤0.01%	2916
2020 Q4	$8K	Hold	4,000	–	–	﹤0.01%	2367
2020 Q3	$10K	Buy	4,000 +3,000	+300%	+$8.23K	﹤0.01%	2125
2020 Q2	$3K	Hold	1,000	–	–	﹤0.01%	2363
2020 Q1	$2K	Hold	1,000	–	–	﹤0.01%	2258
2019 Q4	$4K	Hold	1,000	–	–	﹤0.01%	2276
2019 Q3	$4K	Hold	1,000	–	–	﹤0.01%	2277
2019 Q2	$3K	Buy	+1,000	New	+$4.41K	﹤0.01%	2326

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Steward Partners Investment Advisory's ADMA Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its ADMA Biologics (ADMA) stake by 24% in Q2 2026, buying an estimated $13.1K and bringing the position to 7,500 shares worth $62.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2818.

Steward Partners Investment Advisory first reported a position in ADMA in Q2 2019 and has held it in 29 quarters since. The position peaked at $228K in Q3 2024. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

Steward Partners Investment Advisory held 7,500 shares of ADMA Biologics worth $62.8K as of Q2 2026.
Steward Partners Investment Advisory bought 1,438 ADMA Biologics shares in Q2 2026, an estimated $13.1K.
ADMA Biologics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2818 holding.
Steward Partners Investment Advisory first reported a position in ADMA Biologics in Q2 2019 and has held it in 29 quarters since.
Steward Partners Investment Advisory's ADMA Biologics position peaked at $228K in Q3 2024.
322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.